Anne Hermanowski‐Vosatka

Author

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also Known As

A Hermanowski-Vosatka, A. Hermanowski-Vosatka, A. Hermanowski‐Vosatka, Anne Hermanowski-Vosatka, Anne Hermanowski‐Vosatka, Anne Hermanowski–Vosatka

Publications

4.4K

Citations

H-Index

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)Rockefeller University Brigham and Women's Hospital United States Military Academy

About

Anne Hermanowski‐Vosatka is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and inflammation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	23	2.7K
2	Biochemistry	9	9	1.6K
3	Natural Sciences	6	6	1.2K
4	Health Sciences	3	3	134
5	Allergy	1	1	174

Anne Hermanowski‐Vosatka

Publications

4.3K

Citations

H-Index

Page 1

	Year	Citations
Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: implications for human disease. Michael P. Lisanti, Philipp E. Scherer, Jolanta Vidugirienė, The Journal of Cell Biology Proteinlipid InteractionCaveolin-rich Membrane DomainsCytoskeletonCellular PhysiologyMembrane Transport	1994	907
Simvastatin Has Anti-Inflammatory and Antiatherosclerotic Activities Independent of Plasma Cholesterol Lowering Carl P. Sparrow, Charlotte Burton, Melba Hernandez, Arteriosclerosis Thrombosis and Vascular Biology	2001	413
11β-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice Anne Hermanowski‐Vosatka, James M. Balkovec, Kang Cheng, The Journal of Experimental Medicine	2005	362
Activation of the adhesive capacity of CR3 on neutrophils by endotoxin: dependence on lipopolysaccharide binding protein and CD14. Samuel D. Wright, Robert Ramos, Anne Hermanowski‐Vosatka, The Journal of Experimental Medicine Lipopolysaccharide Binding ProteinCell AdhesionImmunologyPathologyCd14 Expression	1991	291
Deficiency in Inducible Nitric Oxide Synthase Results in Reduced Atherosclerosis in Apolipoprotein E-Deficient Mice Patricia A. Detmers, Melba Hernandez, John S. Mudgett, The Journal of Immunology	2000	207
Peroxisome Proliferator-activated Receptor-γ Ligands Inhibit Adipocyte 11β-Hydroxysteroid Dehydrogenase Type 1 Expression and Activity Joel P. Berger, Michael Tanen, Alex Elbrecht, Journal of Biological Chemistry	2001	206
Infectious Agents Are Not Necessary for Murine Atherogenesis Samuel D. Wright, Charlotte Burton, Melba Hernandez, The Journal of Experimental Medicine InflammationHost ResponsePathogenicityInfectious AgentsPathogenesis	2000	176
11β-Hydroxysteroid Dehydrogenase Type 1 Is Induced in Human Monocytes upon Differentiation to Macrophages Rolf Thieringer, Cheryl B. Le Grand, Linda Carbin, The Journal of Immunology Chronic Inflammatory DiseasesImmunologyGlucocorticoidInflammationCell Signaling	2001	174
Integrin modulating factor-1: A lipid that alters the function of leukocyte integrins Anne Hermanowski‐Vosatka, Jos A. G. van Strijp, William J. Swiggard, Cell InflammationCytokinePhysiologyImmunologyCell-matrix Interaction	1992	163
Effects of an 11 <i>β</i> ‐hydroxysteroid dehydrogenase type 1 inhibitor, MK‐0916, in patients with type 2 diabetes mellitus and metabolic syndrome P. U. Feig, Sukrut Shah, Anne Hermanowski‐Vosatka, Diabetes Obesity and Metabolism	2011	157

Page 1